+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis



Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis



European Journal of Clinical Microbiology and Infectious Diseases 14(10): 899-903



The major surface antigen from the proliferative form of Toxoplasma gondii (P-30 of SAG-1) was chosen as a target for exploration of Toxoplasma gondii reactivation in sera from immunocompromised patients. Samples were obtained from 37 HIV-infected subjects with lymphocyte levels of CD4+ < 200/mm3. The prevalence of IgG antibodies to Toxoplasma gondii was 64.9%. Ten patients had clinical symptoms of reactivated toxoplasmosis; eight of these had Toxoplasma encephalitis. The SAG-1 epitopes were found as circulating antigen in five cases with an immunocapture enzyme immunoassay (EIA). The EIA was improved with an IgG1 monoclonal antibody to SAG-1 and a streptavidinbiotin amplification. The sensitivity, specificity and positive predictive value were 30, 92 and 60%, respectively. The SAG-1 levels were compared with different biological parameters such as HIV p24 antigen, beta 2 microglobulin, CD4+ cell count and IgG antibodies to Toxoplasma gondii. The levels of SAG-1 in these patients were significantly higher than those in the 75 healthy control persons with or without a chronic Toxoplasma gondii infection. Therefore, SAG-1 may be involved as a marker of reactivated toxoplasmosis in HIV-infected patients.

(PDF emailed within 1 workday: $29.90)

Accession: 047807469

Download citation: RISBibTeXText

PMID: 8605904


Related references

Immunochemical identification and detection of a 36-kDa Toxoplasma gondii circulating antigen in sera of infected women for laboratory diagnosis of toxoplasmosis. Journal of Immunoassay and Immunochemistry 27(1): 45-60, 2006

Immunoreactivity Analysis of Toxoplasma gondii Recombinant Antigen rSAG3 in Sera from Immunized BALB/c Mice and Toxoplasmosis Patients. Iranian Journal of Public Health 45(7): 911-916, 2016

Production and Evaluation of Toxoplasma gondii Recombinant Surface Antigen 1 (SAG1) for Serodiagnosis of Acute and Chronic Toxoplasma Infection in Human Sera. Iranian Journal of Parasitology 7(3): 1-9, 2012

Analysis of Toxoplasma gondii antigens with sera from toxoplasmosis patients. Revista Da Sociedade Brasileira de Medicina Tropical 31(3): 271-277, 1998

Combinations of three immunological assays for detecting anti-Toxoplasma IgG in the sera of patients infected with Toxoplasma gondii. Southeast Asian Journal of Tropical Medicine and Public Health 28(2): 335-338, 1997

Toxoplasma gondii: detection of MIC10 antigen in sera of experimentally infected mice. Experimental Parasitology 118(3): 362-371, 2007

Diagnosis of human toxoplasmosis by using the recombinant truncated surface antigen 1 of Toxoplasma gondii. Diagnostic Microbiology and Infectious Disease 64(3): 261-266, 2009

Study of specific IgM, IgG, IgA and IgE to toxoplasma GONDII antigens and sCD23 in sera of toxoplasmosis patients. Journal of Allergy & Clinical Immunology 99(1 PART 2): S341, 1997

Analyses of antigen presentation of Toxoplasma gondii-infected cells and Toxoplasma gondii-infected cell-specific CTL. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 344, 1995

Cytotoxic activity of monocytes against Toxoplasma gondii in acute, chronic and reactivated murine toxoplasmosis. Medical Microbiology and Immunology 177(6): 339-348, 1988

Investigation of IgG and IgM class anti-Toxoplasma gondii antibodies in toxoplasmosis suspected patients sera. Acta Parasitologica Turcica 21(3): 245-247, 1997

Seroprevalence of toxoplasmosis in 346 HIV infected patients in the east of France. Serological follow-up study in patients not infected with Toxoplasma gondii. Presse Medicale 21(8): 394-395, 1992

Detection of nucleoside triphosphate hydrolase as a circulating antigen in sera of mice infected with Toxoplasma gondii. Infection and Immunity 55(5): 1332-1335, 1987

Analysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype I in clinical toxoplasmosis. Molecular Biology Reports 37(6): 2927-2933, 2010

Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology 4(10): 1363-1379, 2010